Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Jul | May | April | Mar | Feb | Jan

	Dr. Reddy’s Q3 FY08 Revenue at Rs 12,320 million; EBITDA at Rs 2,037 million January 25, 2008
	Dr. Reddy’s announces settlement of Exelon® (rivastigmine tartrate) ANDA litigation with Novartis January 21, 2008
	Dr. Reddy's to release Q3FY08 results on January 25, 2008; Earnings call slated for January 25, 6.30 PM IST/8.00 AM EST January 18, 2008
	Dr. Reddy's launches Supanac® - (Diclofenac potassium) January 16, 2008

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.